HLA signatures as pathophysiological discriminants of microscopic colitis subtypes.

GWAS HLA Microscopic colitis collagenous colitis genetics

Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
28 Sep 2023
Historique:
received: 17 05 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: aheadofprint

Résumé

Microscopic colitis (MC) is currently regarded as an inflammatory bowel disease that manifests as two subtypes: collagenous colitis (CC) and lymphocytic colitis (LC). Whether these represent a clinical continuum or distinct entities is, however, an open question. Genetic investigations may contribute important insight into their respective pathophysiology. We conducted a GWAS meta-analysis in 1,498 CC and 373 LC patients and 13,487 controls from Europe and US, combined with publicly available MC GWAS data from UK Biobank and FinnGen (2,599 MC cases and 552,343 controls in total). HLA alleles and polymorphic residues were imputed and tested for association, including conditional analyses for the identification of key causative variants and residues. Genetic correlations with other traits and diagnoses were also studied. We detected strong HLA association with CC, and conditional analyses highlighted the DRB1*03:01 allele and its residues Y26, N77 and R74 as key to this association (best P=1.4×10 -23, OR=1.96). Nominally significant genetic correlations were detected between CC and Pneumonia (rg=0.77; P=0.048) and oesophageal diseases (rg=0.45, P=0.023). An additional locus was identified in MC GWAS analyses near the CLEC16A and RMI2 genes on chromosome 16 (rs35099084, P=2.0×10 -8, OR=1.31). No significant association was detected for LC. Our results suggest CC and LC have distinct pathophysiological underpinnings, characterised by an HLA predisposing role only in CC. This challenges existing classifications, eventually calling for a re-evaluation of the utility of MC umbrella definitions.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Microscopic colitis (MC) is currently regarded as an inflammatory bowel disease that manifests as two subtypes: collagenous colitis (CC) and lymphocytic colitis (LC). Whether these represent a clinical continuum or distinct entities is, however, an open question. Genetic investigations may contribute important insight into their respective pathophysiology.
METHODS METHODS
We conducted a GWAS meta-analysis in 1,498 CC and 373 LC patients and 13,487 controls from Europe and US, combined with publicly available MC GWAS data from UK Biobank and FinnGen (2,599 MC cases and 552,343 controls in total). HLA alleles and polymorphic residues were imputed and tested for association, including conditional analyses for the identification of key causative variants and residues. Genetic correlations with other traits and diagnoses were also studied.
RESULTS RESULTS
We detected strong HLA association with CC, and conditional analyses highlighted the DRB1*03:01 allele and its residues Y26, N77 and R74 as key to this association (best P=1.4×10 -23, OR=1.96). Nominally significant genetic correlations were detected between CC and Pneumonia (rg=0.77; P=0.048) and oesophageal diseases (rg=0.45, P=0.023). An additional locus was identified in MC GWAS analyses near the CLEC16A and RMI2 genes on chromosome 16 (rs35099084, P=2.0×10 -8, OR=1.31). No significant association was detected for LC.
CONCLUSION CONCLUSIONS
Our results suggest CC and LC have distinct pathophysiological underpinnings, characterised by an HLA predisposing role only in CC. This challenges existing classifications, eventually calling for a re-evaluation of the utility of MC umbrella definitions.

Identifiants

pubmed: 37768647
pii: 7285336
doi: 10.1093/ecco-jcc/jjad165
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Tenghao Zheng (T)

School of Biological Sciences, Monash University, Clayton, Victoria, Australia.
Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

Giulia Roda (G)

Biostructures and Biosystems National Institute (INBB), Rome, Italy.

Yamile Zabana (Y)

Gastroenterology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.

Celia Escudero-Hernández (C)

Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.

Xingrong Liu (X)

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

Ye Chen (Y)

Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.

Leticia Camargo Tavares (L)

School of Biological Sciences, Monash University, Clayton, Victoria, Australia.

Ferdinando Bonfiglio (F)

School of Biological Sciences, Monash University, Clayton, Victoria, Australia.
Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Marie-Rose Mellander (MR)

Department of Clinical Sciences, Lund University, Lund, Sweden.

Izabella Janczewska (I)

Medical Department, Ersta hospital, Stockholm, Sweden.

Lina Vigren (L)

Department of Clinical Sciences, Lund University, Lund, Sweden.

Klas Sjöberg (K)

Department of Clinical Sciences, Lund University, Skane University Hospital, Malmo, Sweden.

Bodil Ohlsson (B)

Department of Clinical Sciences, Lund University, Skane University Hospital, Malmo, Sweden.

Sven Almer (S)

Division of Gastroenterology, Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.

Jonas Halfvarson (J)

Department of Gastroenterology, Faculty of Medicine and Health, Orebro University Hospital, Örebro, Sweden.

Stephan Miehlke (S)

Centre for Digestive Diseases, Internal Medicine Centre Eppendorf, Hamburg, Germany; Centre for Oesophageal Disorders, University Hospital Eppendorf, Hamburg, Germany.

Ahmed Madisch (A)

Department of Gastroenterology, CRH Clinic Siloah, Hannover, Germany.

Wolfgang Lieb (W)

Institute of Epidemiology, Christian-Albrechts-University of Kiel, Kiel, Germany.

Juozas Kupčinskas (J)

Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Rinse K Weersma (RK)

Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands.

Luis Bujanda (L)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, Universidad del País Vasco (UPV/EHU), San Sebastian, Spain.

Antonio Julià (A)

Rheumatology Research Group, Vall d' Hebron Research Institute, Barcelona, Spain.

Sara Marsal (S)

Rheumatology Research Group, Vall d' Hebron Research Institute, Barcelona, Spain.

Maria Esteve (M)

Gastroenterology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.

Danila Guagnozzi (D)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
Department of Gastroenterology, Vall d'Hebron University Hospital, Neuro-Immuno-Gastroenterology Group, Digestive System Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.

Fernando Fernández-Bañares (F)

Gastroenterology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.

Carmen Ferrer (C)

Pathology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain.

Inga Peter (I)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Jonas F Ludvigsson (JF)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Darrell Pardi (D)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

Bas Verhaegh (B)

Division Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, Netherlands.

Daisy Jonkers (D)

Division Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, Netherlands.

Marieke Pierik (M)

Division Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, Netherlands.

Andreas Münch (A)

Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Department of Gastroenterology and Hepatology, Linköping University, Linköping, Sweden.
Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.

Andre Franke (A)

Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.

Francesca Bresso (F)

Division of Gastroenterology, Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.

Hamed Khalili (H)

Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Jean-Frederic Colombel (JF)

The Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Mauro D'Amato (M)

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Gastrointestinal Genetics Lab, CIC bioGUNE - BRTA, Derio, Spain.
Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
Department of Medicine and Surgery, LUM University, Casamassima, Italy.

Classifications MeSH